Manufacturing

Articles

The companies are collaborating to apply ShapeTX’s AAVid capsid discovery platform and transgene engineering technology in addition to Otsuka’s expertise in genetic payload design and ophthalmology to develop novel treatment options for eye diseases.

Otsuka Collaborates with ShapeTX for Development of AAV Gene Therapies

The agreement states that Orbit will implement its bead-based peptide display engine to discover peptide leads specific to targets related to specific tumors.

Orano Med and Orbit Discovery Enter Collaboration for New Novel Targeted Radioligand Therapies 

Feliza Mirasol is the science editor for 

Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.

Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing

The launch of Alpha Teknova’s new manufacturing facility in Hollister, Calif., increases its capacity for custom reagents for life sciences applications.

Teknova Opens New GMP Manufacturing Facility for Life Sciences Reagents 

The site was acquired by AGC Biologics in July 2020, and the Milan location is the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies.

AGC Biologics Completes Expansion at CGT Manufacturing Site in Milan

The initial collaboration between the two companies began in 2017 with an extension announced in 2021.

Regeneron Pharmaceuticals to Acquire Decibel Therapeutics 

The bioreactors can integrate with Emerson’s DeltaV PK Controller in addition to S-Series and M-Series controllers.

Sartorius and Emerson Collaborate to Expedite New Therapies to Market

FDA has approved Roctavian (valoctocogene roxaparvovec-rvox), a gene therapy from BioMarin Pharmaceutical for treating severe hemophilia A in adults.

FDA Approves BioMarin’s Roctavian, the First Gene Therapy for Treating Severe Hemophilia A

Jennifer Markarian is a contributing editor for 

Manufacturers face the challenge of meeting growing demand for personalized biopharmaceuticals.

Automation Aids Cell and Gene Therapy Production

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

The prestigious award, worth €20,000 (US$22,000), goes to Maurice Michel of the Science for Life Laboratory at Karolinska Institutet, Stockholm, Sweden. 

Manufacturing, Gene Therapies